Management Strategies for Recurrent Platinum-Resistant Ovarian Cancer

Overview of attention for article published in Drugs, November 2012

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

patent: 2 patents

Citations

dimensions_citation: 136 Dimensions

Readers on

mendeley: 77 Mendeley

Summary Patents Dimensions citations

So far, Dimensions has found 136 publications that cite this research output.

136

The most recent citing publications are shown below. View all 136 publications that cite this research output on Dimensions.

Case report: Interstitial implantation radiotherapy combined with immunotherapy and GM-CSF in oligometastatic platinum-resistant ovarian cancer

Article in Frontiers in Immunology (January 2024)

Randomized phase 2 trial of tremelimumab and durvalumab in combination versus sequentially in recurrent platinum‐resistant ovarian cancer

Article in Cancer (November 2023)

Dynamic Monitoring of CD200 Mediated by Ascites-Derived Exosomes as a Predictor of Survival and Response to Front-Line Chemotherapeutics in Advanced High-Grade Serous Ovarian Cancer

Article in Clinical and Experimental Obstetrics & Gynecology (October 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.